Visit to Burundi

We are visiting Burundi this coming week, from Mar 16 to 20, to work with Dr John Cropsey and his team, in the eye hospital in Kibuye. Dr Cropsey, with his wife Jessica and their kids, Elise, Micah & Sam, now lives and works in Kibuye, Burundi. He completed his ophthalmology residency at Wills Eye Institute


Is Avastin better than Lucentis for AMD?

A group of researchers from China have evaluated randomized controlled clinical trials from around the world to study the efficacy and safety of Avastintm (bevacizumab) versus Lucentistm (ranibizumab) in wet (neovascular) age-related macular degeneration (AMD).

Telemedicine of ROP babies makes for early diagnosis and treatment

Retinopathy of prematurity (ROP) continues to be an ongoing challenge for both ophthalmologists and neonatologists and remains a significant threat to vision for extremely premature infants despite the availability of therapeutic modalities. It remains a leading cause of morbidity despite, (and interestingly) as well as because of, advances in neonatal care, which have improved survival


AMD may be triggered by tiny mineral deposits in retina

Scientists from the University of Maryland School of Medicine have found that tiny lumps of calcium phosphate may be an important triggering factor for age-related macular degeneration (AMD). This is the first time these mineral deposits have been implicated in the disease, which affects more than 10 million Americans.